| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein-lysine 6-oxidase activity | 1.76e-05 | 5 | 27 | 2 | GO:0004720 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor | 2.09e-04 | 16 | 27 | 2 | GO:0016641 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors | 3.30e-04 | 20 | 27 | 2 | GO:0016638 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-AMP phosphodiesterase activity | 4.00e-04 | 22 | 27 | 2 | GO:0004115 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-GMP phosphodiesterase activity | 4.77e-04 | 24 | 27 | 2 | GO:0047555 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-nucleotide phosphodiesterase activity | 5.18e-04 | 25 | 27 | 2 | GO:0004114 | |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 6.05e-04 | 27 | 27 | 2 | GO:0004112 | |
| GeneOntologyMolecularFunction | calcium channel activity | 6.88e-04 | 129 | 27 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.09e-03 | 151 | 27 | 3 | GO:0015085 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine oxidation | 1.52e-05 | 5 | 26 | 2 | GO:0018057 | |
| GeneOntologyBiologicalProcess | cAMP catabolic process | 5.47e-05 | 9 | 26 | 2 | GO:0006198 | |
| GeneOntologyBiologicalProcess | protein oxidation | 1.38e-04 | 14 | 26 | 2 | GO:0018158 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide catabolic process | 1.38e-04 | 14 | 26 | 2 | GO:0009214 | |
| Domain | Lysyl_oxidase | 1.86e-05 | 5 | 26 | 2 | IPR001695 | |
| Domain | Lysyl_oxidase_CS | 1.86e-05 | 5 | 26 | 2 | IPR019828 | |
| Domain | LYSYL_OXIDASE | 1.86e-05 | 5 | 26 | 2 | PS00926 | |
| Domain | Lysyl_oxidase | 1.86e-05 | 5 | 26 | 2 | PF01186 | |
| Domain | PDEase | 3.14e-04 | 19 | 26 | 2 | IPR023088 | |
| Domain | PDEase_I | 3.85e-04 | 21 | 26 | 2 | PF00233 | |
| Domain | PDEASE_I | 3.85e-04 | 21 | 26 | 2 | PS00126 | |
| Domain | PDEase_CS | 3.85e-04 | 21 | 26 | 2 | IPR023174 | |
| Domain | - | 4.23e-04 | 22 | 26 | 2 | 1.10.1300.10 | |
| Domain | PDEase_catalytic_dom | 4.63e-04 | 23 | 26 | 2 | IPR002073 | |
| Domain | HDc | 5.05e-04 | 24 | 26 | 2 | SM00471 | |
| Domain | HD/PDEase_dom | 5.05e-04 | 24 | 26 | 2 | IPR003607 | |
| Domain | Cys-rich_flank_reg_C | 6.92e-03 | 90 | 26 | 2 | IPR000483 | |
| Domain | LRRCT | 6.92e-03 | 90 | 26 | 2 | SM00082 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FYN | 5.32e-05 | 7 | 23 | 2 | M27912 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 9.42e-05 | 55 | 23 | 3 | M39763 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 3.01e-04 | 16 | 23 | 2 | MM14699 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 3.83e-04 | 18 | 23 | 2 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 3.83e-04 | 18 | 23 | 2 | MM14882 | |
| Pathway | WP_SILDENAFIL_TREATMENT | 6.31e-04 | 23 | 23 | 2 | M46455 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 6.88e-04 | 24 | 23 | 2 | M751 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK2_TRKB | 7.47e-04 | 25 | 23 | 2 | M27864 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 17727341 | ||
| Pubmed | Differential expression of the LOX family genes in human colorectal adenocarcinomas. | 3.48e-06 | 4 | 27 | 2 | 19724858 | |
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 24732776 | ||
| Pubmed | PAN-selective inhibition of cAMP-phosphodiesterase 4 (PDE4) induces gastroparesis in mice. | 3.48e-06 | 4 | 27 | 2 | 32738081 | |
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 22946044 | ||
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 8413254 | ||
| Pubmed | Assessment of PDE4 Inhibitor-Induced Hypothermia as a Correlate of Nausea in Mice. | 3.48e-06 | 4 | 27 | 2 | 34943270 | |
| Pubmed | Lysyl oxidases: a novel multifunctional amine oxidase family. | 3.48e-06 | 4 | 27 | 2 | 11642359 | |
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 33609559 | ||
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 9371714 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 29758265 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 8586960 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 33944911 | ||
| Pubmed | 5.80e-06 | 5 | 27 | 2 | 21740577 | ||
| Pubmed | Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum. | 8.69e-06 | 6 | 27 | 2 | 18923023 | |
| Pubmed | Lysyl oxidase (lox) gene deficiency affects osteoblastic phenotype. | 1.62e-05 | 8 | 27 | 2 | 19458888 | |
| Pubmed | 2.08e-05 | 9 | 27 | 2 | 26954549 | ||
| Pubmed | 2.60e-05 | 10 | 27 | 2 | 23357697 | ||
| Pubmed | 4.08e-05 | 251 | 27 | 4 | 27507650 | ||
| Pubmed | Chromosome localizations of genes for five cAMP-specific phosphodiesterases in man and mouse. | 4.50e-05 | 13 | 27 | 2 | 8009369 | |
| Pubmed | Loss of Lysyl Oxidase-like 3 Attenuates Embryonic Lung Development in Mice. | 6.06e-05 | 15 | 27 | 2 | 27645581 | |
| Pubmed | 6.92e-05 | 16 | 27 | 2 | 22076464 | ||
| Pubmed | 7.21e-05 | 104 | 27 | 3 | 9205841 | ||
| Pubmed | 1.09e-04 | 20 | 27 | 2 | 23791195 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.69e-04 | 1105 | 27 | 6 | 35748872 | |
| Pubmed | 1.72e-04 | 25 | 27 | 2 | 17307970 | ||
| Pubmed | 2.39e-04 | 156 | 27 | 3 | 22008794 | ||
| Pubmed | Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. | 2.66e-04 | 31 | 27 | 2 | 14684825 | |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 3.13e-04 | 171 | 27 | 3 | 20201926 | |
| Pubmed | 4.74e-04 | 197 | 27 | 3 | 36604605 | ||
| GeneFamily | Phosphodiesterases | 2.27e-04 | 24 | 17 | 2 | 681 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 145 | 27 | 4 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.66e-06 | 162 | 27 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.61e-06 | 186 | 27 | 4 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Astrocyte|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 6.14e-06 | 200 | 27 | 4 | b9bd6c4381c92bfc1bfff9aa778a62a41d08f1ef | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 6.14e-06 | 200 | 27 | 4 | be1abe5bb1ce4e7dfec63af4ed0fc5b96bf77866 | |
| ToppCell | Severe-Myeloid-Mast-|Severe / Condition, Lineage, Cell class and cell subclass | 9.06e-05 | 145 | 27 | 3 | ce307d45425a5191882078f049f85477eec40b69 | |
| ToppCell | Severe-Myeloid-Mast|Severe / Condition, Lineage, Cell class and cell subclass | 9.06e-05 | 145 | 27 | 3 | e0bfd2ffdbd6c197ef0a04e983396ebd87ef7127 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.30e-04 | 164 | 27 | 3 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 165 | 27 | 3 | af59a095ecc6758abc13d763c00e44447c488167 | |
| ToppCell | critical-Myeloid-Mast_cell|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.33e-04 | 165 | 27 | 3 | 34a1cc6ccd46c059354e8fbde1ac69f202695a4e | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 165 | 27 | 3 | 84eca6a0f5e996b6955ae79fa102af239098fe8f | |
| ToppCell | NS-critical-d_07-13-Myeloid-Mast_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.38e-04 | 167 | 27 | 3 | 8a14fd980d8ebe8ef0216221f619d31aaa27ff15 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-stromal_related-FDC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-04 | 169 | 27 | 3 | 49a54fb2ea9db5c45e107f304838c536908308bb | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 170 | 27 | 3 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 170 | 27 | 3 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 170 | 27 | 3 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-04 | 172 | 27 | 3 | 13d7117f92a92d77d6b4335ed800c585dc8b4511 | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-04 | 172 | 27 | 3 | 3d83b2f03ad3af4dae3fe6cc0a0ef356872ca94f | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-04 | 172 | 27 | 3 | a3d431aed12c1192e8dca1dc85b8340fb7354f8d | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-04 | 172 | 27 | 3 | 028a5441242b2cc760cafc1822120180619c63ae | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-04 | 172 | 27 | 3 | 9fc70b1a143a8ec910336c23b761d908bb6aecb2 | |
| ToppCell | (03)_Secretory-(0)_uninjured|(03)_Secretory / shred by cell type and Timepoint | 1.55e-04 | 174 | 27 | 3 | ebdddb5091afcc49ab533c890f260f709880c5f9 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-04 | 175 | 27 | 3 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-04 | 176 | 27 | 3 | 8eb91dcf55d4e3e28a72d447181bf6d2ad891fc6 | |
| ToppCell | severe-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.63e-04 | 177 | 27 | 3 | d1ad35ee3d2a84b1d01126d0a38464ab858c00d0 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-04 | 179 | 27 | 3 | 228d12ed1c8dc92aefbcea4aaf7d108783c22be0 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-04 | 179 | 27 | 3 | b8ca29aebd25ebac441bebd769bbf98c536d3166 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-04 | 181 | 27 | 3 | d66838fca0429cad2079cd8d92a5cd33eb0d3522 | |
| ToppCell | Club-club-8|World / Class top | 1.77e-04 | 182 | 27 | 3 | 8111d917e588008d947021460ddf8f1e7ae1337a | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-04 | 182 | 27 | 3 | 5f1f10c845b73d1f69794277925ef847ff23ac2d | |
| ToppCell | severe-Myeloid-Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.80e-04 | 183 | 27 | 3 | 60a6112aa4fc4f5debda4c7e81b37539ba2e4e6e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.80e-04 | 183 | 27 | 3 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.80e-04 | 183 | 27 | 3 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-04 | 184 | 27 | 3 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-04 | 185 | 27 | 3 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-04 | 185 | 27 | 3 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.86e-04 | 185 | 27 | 3 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.86e-04 | 185 | 27 | 3 | f30fb9d75cdb757b206312992aaf7485bc900f96 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.89e-04 | 186 | 27 | 3 | 1a1e5d85a5ad90afee234c12a9b54a5e93a8a2f2 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.89e-04 | 186 | 27 | 3 | f1366638edaecad5cad6367440f4c693513bed7e | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.89e-04 | 186 | 27 | 3 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 186 | 27 | 3 | d8d559daff4aeef334d403fde4e3ee2e4a6086d0 | |
| ToppCell | Mast_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.95e-04 | 188 | 27 | 3 | 229d24b87e945c4d543d11ac70761e45175ba0e5 | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 1.98e-04 | 189 | 27 | 3 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 189 | 27 | 3 | 562f8bf5a7d38afb4a8f2415d617d5f79cfb7e3f | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.98e-04 | 189 | 27 | 3 | b0244a9d1b5c8ad4708750b691184f3491b13900 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 189 | 27 | 3 | 270dd4a0fc5260288fe6829837942c78b40ecec4 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-04 | 190 | 27 | 3 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.08e-04 | 192 | 27 | 3 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 192 | 27 | 3 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 192 | 27 | 3 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | NS-moderate-d_0-4-Myeloid-Resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.11e-04 | 193 | 27 | 3 | e530d4349b257f2590c799bf082ed6318700c526 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 193 | 27 | 3 | 0a665531d581d4e3941e29d3f95569da8f166447 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 193 | 27 | 3 | 24ce1f37cca655415410d2403a52d1ebb3332280 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.14e-04 | 194 | 27 | 3 | f9fbb043411546d8c9e0321a64165d411f44aeb7 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.14e-04 | 194 | 27 | 3 | efd5efed060edb7f24d59600981bb60ec28ac2ef | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-04 | 194 | 27 | 3 | 1dce6d4b6ac41f80677e3e4c335a4f383bd76f85 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-04 | 194 | 27 | 3 | 2d0cff9dc538a14518741e2a96d9d78442c81a72 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-04 | 195 | 27 | 3 | 34a9462f4e843f3065cc58c17ad71c1b5b836ae1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-04 | 196 | 27 | 3 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 196 | 27 | 3 | cbc727b55b6433a701b1a331028a49960fcee6ee | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_2|COVID-19_Mild / Disease condition and Cell class | 2.24e-04 | 197 | 27 | 3 | e844f660010d114d65bd814f3d3fccd8e4a6b8da | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 197 | 27 | 3 | d95565652ca318a2298d6918d54ba6367e9560f4 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-04 | 198 | 27 | 3 | c7dbf24caae5c4ef285845d13055de9e07281bb3 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-04 | 198 | 27 | 3 | 6a4161680b46b2c12353a693c403b5a4bb3da03f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-04 | 198 | 27 | 3 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-04 | 198 | 27 | 3 | 0b41b3d6c2db795320e8b65d40d85fb8b618cc34 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-04 | 198 | 27 | 3 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-04 | 198 | 27 | 3 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-04 | 198 | 27 | 3 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-04 | 198 | 27 | 3 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | severe-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.31e-04 | 199 | 27 | 3 | 17283d75a2a900369f63ed02996e7ede97f46140 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.31e-04 | 199 | 27 | 3 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-04 | 200 | 27 | 3 | 78d75d381cb2b9a4c9eb7c32a07b014eaee39195 | |
| ToppCell | mild-B_intermediate|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.34e-04 | 200 | 27 | 3 | 8e3132a1fe3708f725c5c4077878fb87bbea3678 | |
| ToppCell | severe-B_intermediate|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.34e-04 | 200 | 27 | 3 | 6d0ac3d00400dd5657ee266f7b885381bf790ce1 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.34e-04 | 200 | 27 | 3 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | mild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.34e-04 | 200 | 27 | 3 | fe815824e9e4be3f3db73610e3814a7fd533da65 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-erythrocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-04 | 73 | 27 | 2 | 30374f4d30519ca8cd9582da1f9f906420e50244 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB-7|TCGA-Thymus / Sample_Type by Project: Shred V9 | 1.37e-03 | 91 | 27 | 2 | b05275f84368e3f09da03b2eefaa85f1f22617c4 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.89e-03 | 107 | 27 | 2 | 13af691c8533418d2800a8eca61155896b559948 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.89e-03 | 107 | 27 | 2 | a5a34bb9706527799ddb494d4f1bfc634c29e8a9 | |
| ToppCell | |World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.41e-03 | 121 | 27 | 2 | da8fe561dcf50792d0cbcaad383d564f900a6677 | |
| ToppCell | frontal_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.45e-03 | 122 | 27 | 2 | c16110934172f174f4aefe14b81abce8514b30f0 | |
| ToppCell | frontal_cortex-Non-neuronal-pericyte_cell-Peri|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.45e-03 | 122 | 27 | 2 | 006ac4f6807e688554d36557d29d5e5a0bc3c36f | |
| ToppCell | frontal_cortex-Non-neuronal-pericyte_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.45e-03 | 122 | 27 | 2 | f3d9a5893fdee3562880fb6fc132b88169a7d997 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Myxofibrosarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.49e-03 | 123 | 27 | 2 | 12b87d06e62f142e18424aae5c87454e78e713f0 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-03 | 126 | 27 | 2 | c3261ea8726400de87f1c8a5a5134ba2b2884f66 | |
| ToppCell | Severe-B_intermediate-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.61e-03 | 126 | 27 | 2 | 42a0bdbe18ef85146cac4e86b2b27d0b3b20d8a2 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Myxofibrosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.82e-03 | 131 | 27 | 2 | c847dcdfb94feb9e1dfc072a162d2b1b6f3d59e4 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.94e-03 | 134 | 27 | 2 | a3547a68012d879d4dfe80394eace70808722e43 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.94e-03 | 134 | 27 | 2 | 9458e2d0dbc18d9025b66b59f3ecc2fbc5384940 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.99e-03 | 135 | 27 | 2 | 7743a01dc9c4542e910e7c0fe046004692a680bf | |
| ToppCell | COVID-19-kidney-Technical/muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.16e-03 | 139 | 27 | 2 | 13247bcb21c57c808657e0f543d6f134eeea7cc1 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 3.16e-03 | 139 | 27 | 2 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.43e-03 | 145 | 27 | 2 | 734d85ca7a2e5e040f433cadc5f9be1f25cf2e91 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.43e-03 | 145 | 27 | 2 | 8ba09eb0fd27f25aa90a3ad75d67a9f79f3f4f43 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.48e-03 | 146 | 27 | 2 | 86cddd0e7f954547b7ffdccb0329cd5c4b725ac1 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.53e-03 | 147 | 27 | 2 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.57e-03 | 148 | 27 | 2 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| Drug | p-toluidine | 1.44e-06 | 71 | 27 | 4 | CID000007813 | |
| Drug | Piclamilast | 8.11e-06 | 4 | 27 | 2 | DB01791 | |
| Drug | Ibudilast | 1.35e-05 | 5 | 27 | 2 | DB05266 | |
| Drug | 1,7-naphthyridine | 1.35e-05 | 5 | 27 | 2 | CID000009209 | |
| Drug | topa quinone | 1.43e-05 | 40 | 27 | 3 | CID000123871 | |
| Drug | ganciclovir | 2.15e-05 | 140 | 27 | 4 | CID000003454 | |
| Drug | Iloprost | 2.83e-05 | 7 | 27 | 2 | DB01088 | |
| Drug | Ketotifen | 2.83e-05 | 7 | 27 | 2 | DB00920 | |
| Drug | Q 192 | 3.78e-05 | 8 | 27 | 2 | CID000077317 | |
| Drug | Dyphylline | 3.78e-05 | 8 | 27 | 2 | DB00651 | |
| Drug | trequinsin | 4.85e-05 | 9 | 27 | 2 | ctd:C035964 | |
| Drug | L-826,141 | 4.85e-05 | 9 | 27 | 2 | ctd:C459562 | |
| Drug | NVP ABE171 | 6.06e-05 | 10 | 27 | 2 | ctd:C451724 | |
| Drug | DOTMA | 6.06e-05 | 10 | 27 | 2 | CID006438350 | |
| Drug | p-azoxyanisole | 6.77e-05 | 67 | 27 | 3 | CID000015277 | |
| Drug | P-38 | 6.79e-05 | 613 | 27 | 6 | CID000200878 | |
| Drug | NSC55260 | 7.40e-05 | 11 | 27 | 2 | CID005356351 | |
| Drug | NSC23615 | 7.54e-05 | 193 | 27 | 4 | CID000000640 | |
| Drug | AC1L73CW | 1.33e-04 | 84 | 27 | 3 | CID000328776 | |
| Drug | milacemide | 1.41e-04 | 15 | 27 | 2 | CID000053568 | |
| Disease | endometrial carcinoma, endometriosis | 4.09e-05 | 11 | 26 | 2 | EFO_0001065, EFO_1001512 | |
| Disease | cognitive function measurement | 1.84e-04 | 1434 | 26 | 7 | EFO_0008354 | |
| Disease | Huntington's disease (is_implicated_in) | 1.87e-04 | 23 | 26 | 2 | DOID:12858 (is_implicated_in) | |
| Disease | Epileptic encephalopathy | 3.20e-04 | 30 | 26 | 2 | C0543888 | |
| Disease | prostate cancer (implicated_via_orthology) | 3.88e-04 | 33 | 26 | 2 | DOID:10283 (implicated_via_orthology) | |
| Disease | thioredoxin domain-containing protein 12 measurement | 5.42e-04 | 39 | 26 | 2 | EFO_0008298 | |
| Disease | alcohol use disorder measurement | 8.65e-04 | 214 | 26 | 3 | EFO_0009458 | |
| Disease | Tourette syndrome | 8.91e-04 | 50 | 26 | 2 | EFO_0004895 | |
| Disease | electrocardiography | 1.12e-03 | 530 | 26 | 4 | EFO_0004327 | |
| Disease | Autistic Disorder | 1.53e-03 | 261 | 26 | 3 | C0004352 | |
| Disease | acute lymphoblastic leukemia | 1.55e-03 | 66 | 26 | 2 | EFO_0000220 | |
| Disease | keratoconus | 1.55e-03 | 66 | 26 | 2 | MONDO_0015486 | |
| Disease | diet measurement | 1.99e-03 | 1049 | 26 | 5 | EFO_0008111 | |
| Disease | Epilepsy, Cryptogenic | 2.37e-03 | 82 | 26 | 2 | C0086237 | |
| Disease | Awakening Epilepsy | 2.37e-03 | 82 | 26 | 2 | C0751111 | |
| Disease | Aura | 2.37e-03 | 82 | 26 | 2 | C0236018 | |
| Disease | Autism Spectrum Disorders | 2.55e-03 | 85 | 26 | 2 | C1510586 | |
| Disease | complement factor D measurement | 3.04e-03 | 93 | 26 | 2 | EFO_0020283 | |
| Disease | subcutaneous adipose tissue measurement | 3.04e-03 | 93 | 26 | 2 | EFO_0004766 | |
| Disease | Neurodevelopmental Disorders | 3.04e-03 | 93 | 26 | 2 | C1535926 | |
| Disease | opioid use disorder | 3.57e-03 | 101 | 26 | 2 | EFO_0010702 | |
| Disease | unipolar depression | 3.63e-03 | 1206 | 26 | 5 | EFO_0003761 | |
| Disease | C-reactive protein measurement | 3.63e-03 | 1206 | 26 | 5 | EFO_0004458 | |
| Disease | Bell's palsy | 3.64e-03 | 102 | 26 | 2 | EFO_0007167 | |
| Disease | asthma | 3.98e-03 | 751 | 26 | 4 | MONDO_0004979 | |
| Disease | alcohol consumption measurement | 4.12e-03 | 1242 | 26 | 5 | EFO_0007878 | |
| Disease | Epilepsy | 4.15e-03 | 109 | 26 | 2 | C0014544 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QHQDHHGAYHSSYLH | 301 | Q8NEC5 | |
| QFNFHTFHLEDHHDY | 1106 | Q7Z407 | |
| YTPLHHQSFHYEFQH | 66 | Q7Z6R9 | |
| CHGHYHSMDIFTHYD | 606 | P58215 | |
| RHYHYCHGNALSHAF | 166 | Q8NGJ5 | |
| EDHYHSDVAYHNSLH | 396 | Q07343 | |
| YHANVAYHNSLHAAD | 381 | Q08493 | |
| SVGYDYHQAKHHHGV | 46 | Q13401 | |
| THQQQFHHSYFHHYH | 381 | O75949 | |
| FHHSYFHHYHQQYHH | 386 | O75949 | |
| HIYLYHHAQAHKALF | 1486 | Q07864 | |
| LMADNYDDDHHHYHH | 911 | O15083 | |
| HSIHHDYHQYFSYNQ | 1361 | Q9Y2I7 | |
| AEKGHYSLHFDAFHH | 1831 | Q8IZD9 | |
| RHHQYEQHWYKDHHY | 1661 | O14647 | |
| HYHYGRFQEHHGKSQ | 381 | Q5T764 | |
| CHQHYHSMDEFSHYD | 291 | P28300 | |
| HEENMHDLQYHTHYA | 321 | Q6AZY7 | |
| NHHHYVAAAFKAHYS | 661 | Q9NT99 | |
| ASHHHVKFHYAFALN | 346 | Q99683 | |
| HHWMYNATSYHHSYE | 371 | Q10713 | |
| CHYEFYFAHHNLFHE | 706 | Q9BXR5 | |
| YFAHHNLFHENSDHI | 711 | Q9BXR5 | |
| SHHYYDNKLPKHGFH | 356 | P61647 | |
| VAAYAESYHQHFAAH | 246 | Q03169 | |
| QQQQPHHHHHYYFYN | 26 | Q7Z417 | |
| HHHHHYYFYNHSHNH | 31 | Q7Z417 | |
| YYFYNHSHNHHHHHH | 36 | Q7Z417 | |
| YKHINGLKYHQAHAH | 506 | O15014 | |
| SAHHTDHHMFFDYNY | 226 | O75845 | |
| KDSNVYQDHYHHHHR | 976 | Q13224 |